Tau, a diastolic ventricular relaxation parameter, showed a trend to be higher in the diabetes group than in controls, and an improving trend with Val or Sac/Val treatment, although the difference was not significant.
← all excerpts
Sacubitril/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice.
1
—
—